Literature DB >> 34994637

Upfront Adjuvant Immunotherapy of Replication Repair-Deficient Pediatric Glioblastoma With Chemoradiation-Sparing Approach.

Trisha Larkin1,2, Anirban Das3,4, Vanessa Bianchi4, Sumedha Sudhaman4, Jiil Chung4, Noor Alsafwani5, Logine Negm4, Anthony Yachnis6, Jason Blatt7, Cynthia Hawkins5, Eric Bouffet3, Uri Tabori3,4, Sridharan Gururangan7.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34994637     DOI： 10.1200/PO.21.00153

Source DB:  PubMed          Journal:  JCO Precis Oncol        ISSN： 2473-4284


× No keyword cloud information.
  1 in total

1.  Durable benefit and change in TCR clonality with nivolumab in a Lynch syndrome-associated glioma.

Authors:  Santiago Cabezas-Camarero; Rebeca Pérez-Alfayate; Vanesa García-Barberán; María Carmen Polidura; María Natividad Gómez-Ruiz; Isabel Casado-Fariñas; Issa Ahmad Subhi-Issa; José Carlos Plaza Hernández; Pilar Garre; Isabel Díaz-Millán; Pedro Pérez-Segura
Journal:  Ther Adv Med Oncol       Date:  2022-06-08       Impact factor: 5.485
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.